Stocks To Watch For Tuesday 07/22/14 – UNGS AEYE TCEL


Hi Everyone & Welcome New Subscribers,

While we continue to wait for updates from our profiled pick, UNGS , which should be soon forthcoming, we will continue to incorporate a variety of other tickers to keep a watchful eye on for quick, profitable trades.

UNGS is by far our most favorite pick at just .002 per share as we await word regarding the company’s previously announced intent to acquire a high-end, automated retail kiosk company which expects to generate $5M in revenues for 2014, and plans to focus on the medical marijuana dispensing industry, Signifi Solutions (

AEYE (AudioEye, Inc.) continues to create new highs from our initial watch list alert two weeks ago at .60, now up more than 50% from that level after reaching a new high of .94, up 20% from our second mention last week. Keep the stock on watch for a potential breach of the $1.00 mark.

TCEL (Therapy Cells, Inc.) closed up by more than 164% today on record trading volume, quadrupling previous records, and should offer more trading opportunities tomorrow; look for a sharp dip off the open price shortly after trading begins.

If You’re Not Making Money, You’re Not Signed Up To The Right Newsletter! Sign Up NOW-> HERE <-For Our FREE Alerts & Updates; UNGS Is Already Up 100% From Our Alert, But We Believe The Best Has Yet To Come!

Happy Trading!


The Penny Stock Experts Team At 

Please read our legal Disclaimer below:

This disclaimer is to be read in its entirety, and fully understood before using or joining the email list. reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Your continued use of the website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS. Neither nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st
ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site. We are neither licensed nor qualified to provide investment advice.

The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website. Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. and/or it’s affiliates may receive compensation for e-mail alerts. To view our full compensation disclosure please visit does not accept free-trading shares as a form of payment. 

We have NOT been compensated for any e-mails, “tweets”, or blog posts related to UNGS, nor do we plan to be in the future. We have no communication with the company or insiders, nor do we plan to. We have purchased up to, but not exceeding, 5,000,000 shares of UNGS stock on the open market, which we plan to trade as we see fit. If unforeseen events (which are out of our control) affect UNGS, we may sell our entire position at any time.